Evaluation of a single-use bioartificial liver (BAL) biocartridge consisting of cryopreservable alginate encapsulated liver cell spheroids as a component of HepatiCan™, a novel bioartificial liver device
Abstract
Introduction: alternative therapies to complement liver transplantation and treat patients with liver failure are not available. In this study, a clinical scale single-use biocartridge was developed for use as part of a novel Bioartificial Liver device (HepatiCan™), utilising conditioned human-derived alginate encapsulated liver spheroids (AELS), within a fluidised bed.
Methods: to develop the optimal biocartridge, two designs (B2 and B3) were created and modelled to best replicate the performance of our preexisting reusable cartridge (B1). The suitability of designs, and their ability to deliver the required hydrodynamic conditions for AELS, during both spheroid production and treatment phases, was addressed by computational fluid dynamics (CFD). Subsequently, the B3 biocartridge was produced and tested under continuous fluidisation conditions for the growth after encapsulation and recovery after cryopreservation of micro-spheroids in hydrogel scaffolds (AELS).
Results: the main difference between the designs in (B2 and B3) was the base plate flow distributor. Preserving the hole pattern in the base plate, between B1 and B3, was critical for mimicking fluid flow. Additionally, increasing the number of orifices in the cross-patterned base plate design (B3) provided further benefits: maintaining homogeneity in fluid velocity distribution, whilst avoiding "dead-flow" zones. During AELS culture (using B3 format), a cell density of 24.27 ± 3.0 × 106 cells/mL of beads was…
Read the paper
Related studies
- A Survey on Knowledge Graphs: Representation, Acquisition, and Applications
- Toxicity of nanomaterials
- The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies
- Halogen bonding (X‐bonding): A biological perspective
- Biofilm formation at the air–liquid interface by the Pseudomonas fluorescens SBW25 wrinkly spreader requires an acetylated form of cellulose
- Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.